Article · 7 Jul 2025
EditorialPublished 2012
Pharmaceutical Regulation: Crossroad of Opportunity as the Distinction between Food and Drugs Blurs
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Elizabeth A. Perry, Rudolph J. Castellani and George Perry PDF Share this article
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Commentary · Mar 2015
Advancements in Novel Drug Delivery Systems and Opportunities for Indian Pharmaceutical companies
Conference abstract · 23 Nov 2012
Concepts, challenges and opportunities in regulatory strategy of Uttar pradesh drugs and pharmaceutical company Ltd
Conference abstract · 24 Sep 2018
Seamless pharmacovigilance practices: Blurring the line between drug safety and pharmacovigilance
Conference abstract · 3 Aug 2015
Brazilian pharmaceutical regulation on productive partnerships for development of priority drugs
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Elizabeth A. Perry”
- BylineArticles whose byline prints “Rudolph J. Castellani”
- BylineArticles whose byline prints “George Perry”

